Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Navika D. Shukla, Ameen A. Salahudeen, Gregory A. Taylor, Suresh S. Ramalingam, Everett E. Vokes, Glenwood D. Goss, Roy H. Decker, Karen Kelly, Giorgio V. Scagliotti, Tony S. Mok, Heather A. Wakelee

Research output: Contribution to journalArticlepeer-review

Abstract

Cancer cooperative groups have historically played a critical role in the advancement of non–small-cell lung cancer therapy. Representatives from cooperative groups worldwide convene at the International Lung Cancer Congress annually. The International Lung Cancer Congress had its 17th anniversary in the summer of 2016. The present review highlights the thoracic malignancy studies discussed by presenters. The included studies are merely a sample of the trials of thoracic malignancies ongoing globally.

Original languageEnglish (US)
JournalClinical Lung Cancer
DOIs
StateAccepted/In press - Jan 1 2018

Keywords

  • Clinical trials
  • Mesothelioma
  • Non–small-cell lung cancer
  • Small cell lung cancer
  • Thymic carcinoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy'. Together they form a unique fingerprint.

Cite this